期刊文献+

他汀类药物致横纹肌溶解综合征及文献复习 被引量:2

Rhabdomyolysis due to irrational use of statins and literature review
原文传递
导出
摘要 他汀类药物在动脉粥样硬化疾病的治疗和预防中得到广泛的应用,但需要注意发生肌病的风险。1例合并慢性肾脏病的高龄女性急性冠脉综合征患者,由于将辛伐他汀剂量加倍,导致发生了横纹肌溶解综合征,停药并应用血液滤过治疗后病情得到缓解。其发病机制可能与他汀类药物引起的异戊二烯或辅酶Q10缺乏有关。合并慢性肾脏病时,他汀类药物容易在体内蓄积,并导致严重的药物不良反应。 Statins are widely used for prevention and treatment of atherosclerosis, constant vigilance is necessary in order to avoid myopathy. In an old female patient with chronic kidney disease complicated by acute coronary syndrome,rhabdomyolysis occured due to double dose of simvastatin, she recovered after drug withdrawal and use of hemofiltration. The pathogenesis may be statin-induced isoprenoid or ubiquinon deficiency. In chronic kidney disease, statins tend to accumulate in human body, and cause severe adverse drug reaction.
作者 李辉 汪芳
机构地区 北京医院心内科
出处 《临床药物治疗杂志》 2013年第3期51-53,共3页 Clinical Medication Journal
关键词 他汀类药物 横纹肌溶解综合征 动脉粥样硬化 Statins Rhabdomyolysis Atherosclerosis
  • 相关文献

参考文献8

  • 1S Antonopoulos AS,Margaritis M,Lee R,et al.Statins as Anti-Inflammatory Agents in Atherogenesis:Molecular Mechanisms and Lessons from the Recent Clinical Trials[J].Curr Pharm Des,2012,18(11):1519-1530.
  • 2张文,陈楠,陈晓农,任红,朱萍,汪关煜.横纹肌溶解综合征致急性肾衰竭23例诊治分析[J].中国危重病急救医学,2003,15(2):73-76. 被引量:52
  • 3Abd TT,Jacobson TA.Statin-induced myopathy:a review and update[J].Expert Opin Drug Saf,2011,10(3):373-387.
  • 4Vaklavas C,Chatzizisis YS,Ziakas A,et al.Molecular basis of statin-associated myopathy[J].Atherosclerosis,2009,202(1):18-28.
  • 5P iv H,Thelen KM,Van Coster R,et al.High-dose statins and skeletal muscle metabolism in humans:a randomized controlled trial[J].Clin Pharmacol Ther,2005,78(1)::60-68.
  • 6Joy TR,Hegele RA.Narrative review:statin-related myopathy[J].Ann Intern Med,2009,150(12):858-868.
  • 7Silva M,Matthews ML,Jarvis C,et al.Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy[J].Clin Ther,2007,29(2):253-260.
  • 8European Association for Cardiovascular Prevention&Rehabilitation,Reiner Z,Catapano AL,et al.ESC/EAS Guidelines for the management of dyslipidaemias:the Task Force for the management of dyslipidaemias of the European Society of Cardiology(ESC)and the European Atherosclerosis Society(EAS)[J].Eur Heart J,2011,32(14):1769-1818.

二级参考文献3

共引文献51

同被引文献27

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部